BioSpace News Archive

Business

Lyndra Therapeutics President and Chief Operations Officer Jessica Ballinger Named to National Small Business Association (NSBA) Leadership Council

Lyndra Therapeutics announced that President and Chief Operations Officer Jess Ballinger has been named to the National Small Business Association Leadership Council, joining other advocates from across the country as they work to promote the interests of small business to policymakers in Washington, D.C.

June 16, 2022
·
3 min read
Pharm Country

Esteve Launches INBRIJA® in Germany

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Esteve Pharmaceuticals GmbH has launched INBRIJA ® 33 mg (levodopa inhalation powder, hard capsules) in Germany.

June 16, 2022
·
5 min read
Genetown

Relay Therapeutics Announces Timing of Virtual Analyst and Investor Event

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced registration is open for the virtual analyst and investor event on June 27, 2022 from 8:00 a.m. to 9:00 a.m. ET.

June 16, 2022
·
1 min read
Business

Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President

Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced the promotion of Martin Huber, M.D., to president of Xilio.

June 16, 2022
·
8 min read
Business

Eikon Therapeutics Announces Long-Term Lease with Alexandria Real Estate Equities, Inc. for New Corporate Headquarters in the San Francisco Bay Area

Eikon Therapeutics Inc., a California-based biotechnology company that applies advanced engineering and high-performance computing to the identification of important new medicines, announced the execution of a long-term lease with Alexandria Real Estate Equities, Inc. for its new corporate headquarters.

June 16, 2022
·
4 min read
Business

GlycoEra AG Announces Appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer

R&D leader will execute company’s strategic focus on leveraging CustomGlycan to develop novel therapeutics that degrade circulating and membrane proteins that cause disease.

June 16, 2022
·
3 min read
Business

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

Koneksa , a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) in collaboration with Northwestern University.

June 16, 2022
·
2 min read
Business

Tachyum Signs Memorandum of Understanding with KInIT

Tachyum ™ today announced it has entered into an agreement with Kempelen Institute of Intelligent Technologies (KInIT) in Slovakia to collaborate on scientific research and innovations in artificial intelligence (AI); initiate scientific and commercial cooperation on matters of common interest.

June 16, 2022
·
4 min read
Lone Star Bio

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease.

June 16, 2022
·
5 min read
Business

PerkinElmer and Novartis Collaborate to Address the Unmet Need of Sickle Cell Disease in Sub-Saharan Africa

PerkinElmer’s contributions to the Novartis Africa Sickle Cell Disease program will accelerate access to sickle cell disease screening and treatment across the continent.

June 16, 2022
·
4 min read